Fish oil prevents recurrence of atrial fibrillation 29 Nov 2011 0 comments Fish oil has a significant anti-arrhythmic effect, with omega-3 rich supplements preventing recurrence of atrial fibrillation after electrical cardioversion, Australian cardiologists have shown.
AF burden increases 31 Aug 2010 0 comments The burden of atrial fibrillation, as measured by hospitalisation, has increased by about 7% a year over the last decade, an Adelaide study has shown.
Common mistakes in arrhythmia management 12 Aug 2010 0 comments Four common mistakes in the management and treatment of arrhythmia can have serious consequences for your patients, says Professor Dave Callans.
Australia's first atrial fibrillation website 8 Jun 2010 0 comments A new Australian website www.atrialfibrillation-au.orgA offering advice, information and support for atrial fibrillation patients and their carers, as well as information and a discussion forum for…
Cardiologists rate AF as third most demanding condition 5 May 2010 0 comments Cardiologists consider atrial fibrillation to be the third most demanding and the second most difficult heart condition to manage, international research shows.
Local guidelines needed for initial treatment of AF 14 Apr 2010 0 comments There is a wide variation in the way emergency and cardiology specialists manage atrial fibrillation, researchers have found.
Anti-arrhythmic 'half a step forward’ says review 7 Apr 2010 0 comments The anti-arrhythmic drug dronedarone, currently not licensed in Australia, is half as effective as amiodrane and has no clear safety benefits, a review of the drug concludes.
Research needed into effect of radiation on ICDs 9 Mar 2010 0 comments Australian cardiologists and radiation therapists are calling for more research into the effects of radiation on modern day pacemakers and ICDs.
Exercise can revert AF to sinus rhythm 8 Mar 2010 0 comments Exercise can revert atrial fibrillation to sinus rhythm in some patients, Australian research suggests.
NT-proBNP a strong predictor of AF 28 Oct 2009 0 comments N-terminal pro-B-type natriuretic peptide is a 'remarkable predictor' of incident atrial fibrillation, even after adjustment for other known risk factors, researchers report.